Low FOXA1 expression predicts good response to neo-adjuvant chemotherapy resulting in good outcomes for luminal HER2-negative breast cancer cases

BACKGROUND: FOXA1 expression is a good prognostic marker for endocrine therapy in hormone-positive breast cancer. We retrospectively examined breast cancer patients with luminal human epidermal growth factor receptor 2 (HER2)-negative tumours, as defined by immunohistochemistry, who received neo-adj...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Br J Cancer
Main Authors: Horimoto, Y, Arakawa, A, Harada-Shoji, N, Sonoue, H, Yoshida, Y, Himuro, T, Igari, F, Tokuda, E, Mamat, O, Tanabe, M, Hino, O, Saito, M
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2015
Assuntos:
Translational Therapeutics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4453454/
https://ncbi.nlm.nih.gov/pubmed/25422910
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2014.595
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados